Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Current Leases (2016 - 2025)

Medifast (MED) has disclosed Current Leases for 11 consecutive years, with $4.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Leases fell 25.54% year-over-year to $4.6 million, compared with a TTM value of $4.6 million through Dec 2025, down 25.54%, and an annual FY2025 reading of $4.6 million, down 25.54% over the prior year.
  • Current Leases was $4.6 million for Q4 2025 at Medifast, down from $5.5 million in the prior quarter.
  • Across five years, Current Leases topped out at $6.7 million in Q1 2022 and bottomed at $3.7 million in Q1 2021.
  • Average Current Leases over 5 years is $5.7 million, with a median of $5.9 million recorded in 2023.
  • The sharpest move saw Current Leases skyrocketed 82.5% in 2022, then dropped 25.54% in 2025.
  • Year by year, Current Leases stood at $6.5 million in 2021, then fell by 11.45% to $5.8 million in 2022, then increased by 1.89% to $5.9 million in 2023, then rose by 5.05% to $6.2 million in 2024, then dropped by 25.54% to $4.6 million in 2025.
  • Business Quant data shows Current Leases for MED at $4.6 million in Q4 2025, $5.5 million in Q3 2025, and $5.9 million in Q2 2025.